In essence, aside from a key role in the ATP-adenosine pathway, CD39 functions as a checkpoint in shaping the metabolic adaption and mal-differentiation of CD4+ T cells in the TME of human NSCLC. Here, ENTPD1 is linked to non-small cell lung carcinoma.